NCT00969865View on ClinicalTrials.gov

Individualized Comprehensive Atherosclerosis Risk-reduction Evaluation Program

CompletedOBSERVATIONAL

Enrollment

170

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions

Atherosclerosis

Trial Locations (1)

30309

Piedmont Heart Institute, Atlanta

Sponsors

Lead Sponsor

Piedmont Healthcare

Collaborators (1)

All Listed Sponsors

collaborator

Abbott

INDUSTRY

lead

Piedmont Healthcare

OTHER

NCT00969865 - Individualized Comprehensive Atherosclerosis Risk-reduction Evaluation Program | Biotech Hunter | Biotech Hunter